<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37629005</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The &#x3b5;-Isozyme of Protein Kinase C (PKC&#x3b5;) Is Impaired in ALS Motor Cortex and Its Pulse Activation by Bryostatin-1 Produces Long Term Survival in Degenerating SOD1-G93A Motor Neuron-like Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12825</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241612825</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and ultimately fatal neurodegenerative disease, characterized by a progressive depletion of upper and lower motor neurons (MNs) in the brain and spinal cord. The aberrant regulation of several PKC-mediated signal transduction pathways in ALS has been characterized so far, describing either impaired expression or altered activity of single PKC isozymes (&#x3b1;, &#x3b2;, &#x3b6; and &#x3b4;). Here, we detailed the distribution and cellular localization of the &#x3b5;-isozyme of protein kinase C (PKC&#x3b5;) in human postmortem motor cortex specimens and reported a significant decrease in both PKC&#x3b5; mRNA (<i>PRKCE</i>) and protein immunoreactivity in a subset of sporadic ALS patients. We furthermore investigated the steady-state levels of both pan and phosphorylated PKC&#x3b5; in doxycycline-activated NSC-34 cell lines carrying the human wild-type (WT) or mutant G93A SOD1 and the biological long-term effect of its transient agonism by Bryostatin-1. The G93A-SOD1 cells showed a significant reduction of the phosphoPKC&#x3b5;/panPKC&#x3b5; ratio compared to the WT. Moreover, a brief pulse activation of PKC&#x3b5; by Bryostatin-1 produced long-term survival in activated G93A-SOD1 degenerating cells in two different cell death paradigms (serum starvation and chemokines-induced toxicity). Altogether, the data support the implication of PKC&#x3b5; in ALS pathophysiology and suggests its pharmacological modulation as a potential neuroprotective strategy, at least in a subgroup of sporadic ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>La Cognata</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Agata Grazia</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maugeri</LastName><ForeName>Grazia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0173-4885</Identifier><AffiliationInfo><Affiliation>Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarnaccia</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magr&#xec;</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronica</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3542-3770</Identifier><AffiliationInfo><Affiliation>Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Meibergdreef 9, 1105 Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkon</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Synaptogenix, Inc., New York, NY 10036, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agata</LastName><ForeName>Velia</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-1114-8265</Identifier><AffiliationInfo><Affiliation>Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallaro</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7590-1792</Identifier><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DSB.AD007.304</GrantID><Agency>IRIB-CNR</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI="D051744">Protein Kinase C-epsilon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>37O2X55Y9E</RegistryNumber><NameOfSubstance UI="C046785">bryostatin 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054713">Bryostatins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051744" MajorTopicYN="N">Protein Kinase C-epsilon</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054713" MajorTopicYN="N">Bryostatins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bryostatin-1</Keyword><Keyword MajorTopicYN="N">PKC&#x3b5;</Keyword><Keyword MajorTopicYN="N">PRKCE</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>7</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37629005</ArticleId><ArticleId IdType="pmc">PMC10454105</ArticleId><ArticleId IdType="doi">10.3390/ijms241612825</ArticleId><ArticleId IdType="pii">ijms241612825</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mathis S., Goizet C., Soulages A., Vallat J.M., Masson G.L. Genetics of amyotrophic lateral sclerosis: A review. J. Neurol. Sci. 2019;399:217&#x2013;226. doi: 10.1016/j.jns.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031&#x2013;2041. doi: 10.1016/S0140-6736(07)60944-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60944-1</ArticleId><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile G., Morello G., La Cognata V., Guarnaccia M., Conforti F.L., Cavallaro S. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. J. Pers. Med. 2022;12:770. doi: 10.3390/jpm12050770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050770</ArticleId><ArticleId IdType="pmc">PMC9143965</ArticleId><ArticleId IdType="pubmed">35629192</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile G., La Cognata V., Cavallaro S. The contribution of CNVs to the most common aging-related neurodegenerative diseases. Aging Clin. Exp. Res. 2021;33:1187&#x2013;1195. doi: 10.1007/s40520-020-01485-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01485-4</ArticleId><ArticleId IdType="pubmed">32026430</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine J.S., Doucette P.A., Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 2005;74:563&#x2013;593. doi: 10.1146/annurev.biochem.72.121801.161647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161647</ArticleId><ArticleId IdType="pubmed">15952898</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan V.K., Chakrabartty A. Protein misfolding in the late-onset neurodegenerative diseases: Common themes and the unique case of amyotrophic lateral sclerosis. Proteins. 2013;81:1285&#x2013;1303. doi: 10.1002/prot.24285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.24285</ArticleId><ArticleId IdType="pubmed">23508986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ak&#xe7;imen F., Lopez E.R., Landers J.E., Nath A., Chi&#xf2; A., Chia R., Traynor B.J. Amyotrophic lateral sclerosis: Translating genetic discoveries into therapies. Nat. Rev. Genet. 2023;24:642&#x2013;658. doi: 10.1038/s41576-023-00592-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-023-00592-y</ArticleId><ArticleId IdType="pubmed">37024676</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson S.A., Fang T., De Marchi F., Neel D., Van Weehaeghe D., Berry J.D., Paganoni S. Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents. Drugs. 2022;82:1367&#x2013;1388. doi: 10.1007/s40265-022-01769-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-022-01769-1</ArticleId><ArticleId IdType="pubmed">36121612</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Parton M.J., Leigh P.N. Clinical trials in ALS: An overview. Semin. Neurol. 2001;21:167&#x2013;175. doi: 10.1055/s-2001-15262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2001-15262</ArticleId><ArticleId IdType="pubmed">11442325</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., Morello G., Cavallaro S. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases. Int. J. Mol. Sci. 2021;22:4820. doi: 10.3390/ijms22094820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094820</ArticleId><ArticleId IdType="pmc">PMC8125201</ArticleId><ArticleId IdType="pubmed">34062930</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., Golini E., Iemmolo R., Balletta S., Morello G., De Rosa C., Villari A., Marinelli S., Vacca V., Bonaventura G., et al. CXCR2 increases in ALS cortical neurons and its inhibition prevents motor neuron degeneration in vitro and improves neuromuscular function in SOD1G93A mice. Neurobiol. Dis. 2021;160:105538. doi: 10.1016/j.nbd.2021.105538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105538</ArticleId><ArticleId IdType="pubmed">34743985</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Cavallaro S. Molecular Taxonomy of Sporadic Amyotrophic Lateral Sclerosis Using Disease-Associated Genes. Front. Neurol. 2017;8:152. doi: 10.3389/fneur.2017.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00152</ArticleId><ArticleId IdType="pmc">PMC5395696</ArticleId><ArticleId IdType="pubmed">28469596</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Conforti F.L., D&#x2019;Agata V., Cavallaro S. Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach. J. Mol. Neurosci. 2017;61:563&#x2013;580. doi: 10.1007/s12031-017-0898-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-017-0898-9</ArticleId><ArticleId IdType="pmc">PMC5359376</ArticleId><ArticleId IdType="pubmed">28236105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam O.H., Rozhkov N.V., Shaw R., Kim D., Hubbard I., Fennessey S., Propp N., Consortium N.A., Fagegaltier D., Harris B.T., et al. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep. 2019;29:1164&#x2013;1177 e1165. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Baas F., Iyer A., ten Asbroek A.L., Morello G., Cavallaro S. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol. Dis. 2015;74:359&#x2013;376. doi: 10.1016/j.nbd.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave K.R., Raval A.P., Purroy J., Kirkinezos I.G., Moraes C.T., Bradley W.G., Perez-Pinzon M.A. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: A model of motor neuron disease. Neurobiol. Dis. 2005;18:126&#x2013;133. doi: 10.1016/j.nbd.2004.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2004.08.017</ArticleId><ArticleId IdType="pubmed">15649703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tury A., Tolentino K., Zou Y. Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Dev. Neurobiol. 2014;74:839&#x2013;850. doi: 10.1002/dneu.22137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.22137</ArticleId><ArticleId IdType="pmc">PMC4099310</ArticleId><ArticleId IdType="pubmed">24123880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanius R.A., Paddon H.B., Mezei M., Wagey R., Krieger C., Pelech S.L., Shaw C.A. A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. J. Neurochem. 1995;65:927&#x2013;930. doi: 10.1046/j.1471-4159.1995.65020927.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1995.65020927.x</ArticleId><ArticleId IdType="pubmed">7616256</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Vandoorne T., Steyaert J., Staats K.A., Van Den Bosch L. The multifaceted role of kinases in amyotrophic lateral sclerosis: Genetic, pathological and therapeutic implications. Brain. 2020;143:1651&#x2013;1673. doi: 10.1093/brain/awaa022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa022</ArticleId><ArticleId IdType="pmc">PMC7296858</ArticleId><ArticleId IdType="pubmed">32206784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanuza M.A., Just-Borras L., Hurtado E., Cilleros-Mane V., Tomas M., Garcia N., Tomas J. The Impact of Kinases in Amyotrophic Lateral Sclerosis at the Neuromuscular Synapse: Insights into BDNF/TrkB and PKC Signaling. Cells. 2019;8:1578. doi: 10.3390/cells8121578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121578</ArticleId><ArticleId IdType="pmc">PMC6953086</ArticleId><ArticleId IdType="pubmed">31817487</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger C., Hu J.H., Pelech S. Aberrant protein kinases and phosphoproteins in amyotrophic lateral sclerosis. Trends Pharmacol. Sci. 2003;24:535&#x2013;541. doi: 10.1016/j.tips.2003.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2003.08.003</ArticleId><ArticleId IdType="pubmed">14559406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipka S., Biro T., Czifra G., Griger Z., Gergely P., Brugos B., Tarr T. The role of protein kinase C isoenzymes in the pathogenesis of human autoimmune diseases. Clin. Immunol. 2022;241:109071. doi: 10.1016/j.clim.2022.109071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109071</ArticleId><ArticleId IdType="pubmed">35781096</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton P.M., Messing R.O. The substrates and binding partners of protein kinase Cepsilon. Biochem. J. 2010;427:189&#x2013;196. doi: 10.1042/BJ20091302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20091302</ArticleId><ArticleId IdType="pmc">PMC2966297</ArticleId><ArticleId IdType="pubmed">20350291</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirai Y., Adachi N., Saito N. Protein kinase Cepsilon: Function in neurons. FEBS J. 2008;275:3988&#x2013;3994. doi: 10.1111/j.1742-4658.2008.06556.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2008.06556.x</ArticleId><ArticleId IdType="pubmed">18637121</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kolen K., Pullan S., Neefs J.M., Dautzenberg F.M. Nociceptive and behavioural sensitisation by protein kinase Cepsilon signalling in the CNS. J. Neurochem. 2008;104:1&#x2013;13. doi: 10.1111/j.1471-4159.2007.04986.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04986.x</ArticleId><ArticleId IdType="pubmed">17971128</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill E.N., Mochly-Rosen D. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem. Soc. Trans. 2007;35:1040&#x2013;1042. doi: 10.1042/BST0351040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0351040</ArticleId><ArticleId IdType="pubmed">17956273</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy E., Goldman M., Willems F. Protein kinase C epsilon: A new target to control inflammation and immune-mediated disorders. Int. J. Biochem. Cell Biol. 2004;36:183&#x2013;188. doi: 10.1016/S1357-2725(03)00210-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1357-2725(03)00210-3</ArticleId><ArticleId IdType="pubmed">14643884</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkon D., Sun M.K., Thompson R. Evidence of significant cognitive improvement over baseline in advanced Alzheimer&#x2019;s disease (AD) patients: A regenerative therapeutic strategy. Alzheimers Dement. 2021;17:e050013. doi: 10.1002/alz.050013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.050013</ArticleId></ArticleIdList></Reference><Reference><Citation>Etcheberrigaray R., Tan M., Dewachter I., Kuiperi C., Van der Auwera I., Wera S., Qiao L., Bank B., Nelson T.J., Kozikowski A.P., et al. Therapeutic effects of PKC activators in Alzheimer&#x2019;s disease transgenic mice. Proc. Natl. Acad. Sci. USA. 2004;101:11141&#x2013;11146. doi: 10.1073/pnas.0403921101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403921101</ArticleId><ArticleId IdType="pmc">PMC503753</ArticleId><ArticleId IdType="pubmed">15263077</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T.R., He G., Dobson K., England K., Rumsby M. Phosphorylation at Ser729 specifies a Golgi localisation for protein kinase C epsilon (PKCepsilon) in 3T3 fibroblasts. Cell. Signal. 2007;19:1986&#x2013;1995. doi: 10.1016/j.cellsig.2007.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2007.05.009</ArticleId><ArticleId IdType="pubmed">17611075</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson T.J., Sun M.K., Lim C., Sen A., Khan T., Chirila F.V., Alkon D.L. Bryostatin Effects on Cognitive Function and PKCvarepsilon in Alzheimer&#x2019;s Disease Phase IIa and Expanded Access Trials. J. Alzheimers Dis. 2017;58:521&#x2013;535. doi: 10.3233/JAD-170161.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170161</ArticleId><ArticleId IdType="pmc">PMC5438479</ArticleId><ArticleId IdType="pubmed">28482641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly C., Shimizu A.J., Vargas M.V., Duim W.C., Wender P.A., Olson D.E. Bryostatin 1 Promotes Synaptogenesis and Reduces Dendritic Spine Density in Cortical Cultures through a PKC-Dependent Mechanism. ACS Chem. Neurosci. 2020;11:1545&#x2013;1554. doi: 10.1021/acschemneuro.0c00175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00175</ArticleId><ArticleId IdType="pmc">PMC7332236</ArticleId><ArticleId IdType="pubmed">32437156</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds N.J., Baldassare J.J., Henderson P.A., Shuler J.L., Ballas L.M., Burns D.J., Moomaw C.R., Fisher G.J. Translocation and Downregulation of Protein Kinase C Isoenzymes-&#x3b1; and -&#x3b5; by Phorbol Ester and Bryostatin-1 in Human Keratinocytes and Fibroblasts. J. Investig. Dermatol. 1994;103:364&#x2013;369. doi: 10.1111/1523-1747.ep12394957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1523-1747.ep12394957</ArticleId><ArticleId IdType="pubmed">8077702</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao M., Kato S., Oda M., Hirai S. Decrease of protein kinase C in the spinal motor neurons of amyotrophic lateral sclerosis. Acta Neuropathol. 1998;96:52&#x2013;56. doi: 10.1007/s004010050859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050859</ArticleId><ArticleId IdType="pubmed">9678513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J.H., Chernoff K., Pelech S., Krieger C. Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice. J. Neurochem. 2003;85:422&#x2013;431. doi: 10.1046/j.1471-4159.2003.01669.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01669.x</ArticleId><ArticleId IdType="pubmed">12675918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.B., Rotilio G., Valentine J.S., Carri M.T. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. USA. 2006;103:13860&#x2013;13865. doi: 10.1073/pnas.0605814103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0605814103</ArticleId><ArticleId IdType="pmc">PMC1557633</ArticleId><ArticleId IdType="pubmed">16945901</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Cavallaro S. Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets. Mediat. Inflamm. 2017;2017:7070469. doi: 10.1155/2017/7070469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7070469</ArticleId><ArticleId IdType="pmc">PMC5610842</ArticleId><ArticleId IdType="pubmed">29081603</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico A.G., Maugeri G., Saccone S., Federico C., Cavallaro S., Reglodi D., D&#x2019;Agata V. PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:2943. doi: 10.3390/ijms21082943.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21082943</ArticleId><ArticleId IdType="pmc">PMC7216177</ArticleId><ArticleId IdType="pubmed">32331311</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., D&#x2019;Amico A.G., Maugeri G., Morello G., Guarnaccia M., Magr&#xec; B., Aronica E., D&#x2019;Agata V., Cavallaro S. CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A. Cells. 2023;12:1813. doi: 10.3390/cells12141813.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12141813</ArticleId><ArticleId IdType="pmc">PMC10377984</ArticleId><ArticleId IdType="pubmed">37508478</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Z., Lu X.-T., Jiang X., Tian J. Bryostatin-1: A promising compound for neurological disorders. Front. Pharmacol. 2023;14:7411. doi: 10.3389/fphar.2023.1187411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1187411</ArticleId><ArticleId IdType="pmc">PMC10282138</ArticleId><ArticleId IdType="pubmed">37351510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunesson L., Hellman U., Larsson C. Protein kinase Cepsilon binds peripherin and induces its aggregation, which is accompanied by apoptosis of neuroblastoma cells. J. Biol. Chem. 2008;283:16653&#x2013;16664. doi: 10.1074/jbc.M710436200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M710436200</ArticleId><ArticleId IdType="pubmed">18408015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeidman R., Pettersson L., Sailaja P.R., Truedsson E., Fagerstrom S., Pahlman S., Larsson C. Novel and classical protein kinase C isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells. Int. J. Cancer. 1999;81:494&#x2013;501. doi: 10.1002/(SICI)1097-0215(19990505)81:3&lt;494::AID-IJC26&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0215(19990505)81:3&lt;494::AID-IJC26&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">10209967</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeidman R., Lofgren B., Pahlman S., Larsson C. PKCepsilon, via its regulatory domain and independently of its catalytic domain, induces neurite-like processes in neuroblastoma cells. J. Cell. Biol. 1999;145:713&#x2013;726. doi: 10.1083/jcb.145.4.713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.145.4.713</ArticleId><ArticleId IdType="pmc">PMC2133186</ArticleId><ArticleId IdType="pubmed">10330401</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Tian Q. The role of protein kinase C epsilon in neural signal transduction and neurogenic diseases. Front. Med. 2011;5:70&#x2013;76. doi: 10.1007/s11684-011-0119-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-011-0119-9</ArticleId><ArticleId IdType="pubmed">21681677</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzaki S., Szweda P.A., Szweda L.I., Humphries K.M. Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning. Adv. Drug Deliv. Rev. 2009;61:1324&#x2013;1331. doi: 10.1016/j.addr.2009.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2009.05.008</ArticleId><ArticleId IdType="pmc">PMC2789306</ArticleId><ArticleId IdType="pubmed">19716389</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten S.A., Sihra R.K., Dhami K.S., Coutts C.A., Ali D.W. Differential expression of PKC isoforms in developing zebrafish. Int. J. Dev. Neurosci. 2007;25:155&#x2013;164. doi: 10.1016/j.ijdevneu.2007.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdevneu.2007.02.003</ArticleId><ArticleId IdType="pubmed">17403595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A., Nelson T.J., Alkon D.L., Hongpaisan J. Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer&#x2019;s Disease Hippocampus. J. Alzheimers Dis. 2018;63:1173&#x2013;1189. doi: 10.3233/JAD-171008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-171008</ArticleId><ArticleId IdType="pubmed">29710707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wender P.A., Lippa B., Park C.-M., Irie K., Nakahara A., Ohigashi H. Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes. Bioorg. Med. Chem. Lett. 1999;9:1687&#x2013;1690. doi: 10.1016/S0960-894X(99)00263-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-894X(99)00263-2</ArticleId><ArticleId IdType="pubmed">10397502</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo P.S., Bogi K., Hughes K.M., Beheshti M., Bhattacharyya D., Garfield S.H., Pettit G.R., Blumberg P.M. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1. Cancer Res. 1999;59:6137&#x2013;6144.</Citation><ArticleIdList><ArticleId IdType="pubmed">10626804</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkon D.L., Epstein H., Kuzirian A., Bennett M.C., Nelson T.J. Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning. Proc. Natl. Acad. Sci. USA. 2005;102:16432&#x2013;16437. doi: 10.1073/pnas.0508001102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0508001102</ArticleId><ArticleId IdType="pmc">PMC1283453</ArticleId><ArticleId IdType="pubmed">16258064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani K., Sonoda S., Wakita H., Takahashi Y. Effects of exercise and bryostatin-1 on functional recovery and posttranslational modification in the perilesional cortex after cerebral infarction. NeuroReport. 2023;34:267&#x2013;272. doi: 10.1097/WNR.0000000000001887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0000000000001887</ArticleId><ArticleId IdType="pubmed">36881749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Morimoto E.T., Goodarzi H., Liao J.T., O&#x2019;Keeffe S., Phatnani H.P., Muratet M., Carroll M.C., Levy S., Tavazoie S., et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., Gentile G., Aronica E., Cavallaro S. Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain Regions. Cells. 2020;9:159. doi: 10.3390/cells9010159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010159</ArticleId><ArticleId IdType="pmc">PMC7017305</ArticleId><ArticleId IdType="pubmed">31936368</ArticleId></ArticleIdList></Reference><Reference><Citation>Fetoni A.R., Zorzi V., Paciello F., Ziraldo G., Peres C., Raspa M., Scavizzi F., Salvatore A.M., Crispino G., Tognola G., et al. Cx26 partial loss causes accelerated presbycusis by redox imbalance and dysregulation of Nfr2 pathway. Redox Biol. 2018;19:301&#x2013;317. doi: 10.1016/j.redox.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.08.002</ArticleId><ArticleId IdType="pmc">PMC6129666</ArticleId><ArticleId IdType="pubmed">30199819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura G., Iemmolo R., D&#x2019;Amico A.G., La Cognata V., Costanzo E., Zappia M., D&#x2019;Agata V., Conforti F.L., Aronica E., Cavallaro S. PACAP and PAC1R are differentially expressed in motor cortex of amyotrophic lateral sclerosis patients and support survival of iPSC-derived motor neurons. J. Cell. Physiol. 2018;233:3343&#x2013;3351. doi: 10.1002/jcp.26182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26182</ArticleId><ArticleId IdType="pubmed">28926110</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., Antel J.P. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri G., D&#x2019;Amico A.G., Rasa D.M., Federico C., Saccone S., Morello G., La Cognata V., Cavallaro S., D&#x2019;Agata V. Molecular mechanisms involved in the protective effect of pituitary adenylate cyclase-activating polypeptide in an in vitro model of amyotrophic lateral sclerosis. J. Cell. Physiol. 2019;234:5203&#x2013;5214. doi: 10.1002/jcp.27328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27328</ArticleId><ArticleId IdType="pubmed">30238989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura G., Iemmolo R., Attaguile G.A., La Cognata V., Pistone B.S., Raudino G., D&#x2019;Agata V., Cantarella G., Barcellona M.L., Cavallaro S. iPSCs: A Preclinical Drug Research Tool for Neurological Disorders. Int. J. Mol. Sci. 2021;22:4596. doi: 10.3390/ijms22094596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094596</ArticleId><ArticleId IdType="pmc">PMC8123805</ArticleId><ArticleId IdType="pubmed">33925625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zohar O., Reiter Y., Bennink J.R., Lev A., Cavallaro S., Paratore S., Pick C.G., Brooker G., Yewdell J.W. Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. J. Immunol. 2008;180:6447&#x2013;6451. doi: 10.4049/jimmunol.180.10.6447.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.10.6447</ArticleId><ArticleId IdType="pmc">PMC2727684</ArticleId><ArticleId IdType="pubmed">18453559</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico A.G., Scuderi S., Maugeri G., Cavallaro S., Drago F., D&#x2019;Agata V. NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia. J. Mol. Neurosci. 2014;54:405&#x2013;413. doi: 10.1007/s12031-014-0335-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-014-0335-2</ArticleId><ArticleId IdType="pubmed">24874579</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Guarnaccia M., Spampinato A.G., Salomone S., D&#x2019;Agata V., Conforti F.L., Aronica E., Cavallaro S. Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS. Sci. Rep. 2019;9:9968. doi: 10.1038/s41598-019-46355-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46355-w</ArticleId><ArticleId IdType="pmc">PMC6620285</ArticleId><ArticleId IdType="pubmed">31292500</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>